C3b/iC3b, Human, mAb 3E7 – 100 µg

C3b/iC3b, Human, mAb 3E7 – 100 µg

Antibodies Primary

Article No

182-HM2286-100UG

Species Reactivity

human

Size

100 µg

Clone

3E7

Source / Host

mouse

Shipping Information

Room Temperature

Application

FC, FS, IF

Article No

182-HM2286-100UG

Species Reactivity

human

Size

100 µg

Clone

3E7

Source / Host

mouse

Shipping Information

Room Temperature

Application

FC, FS, IF

Specifications

Application FC, FS, IF
Article No 182-HM2286-100UG
Country Availability SE, FI, DK, NO, EE, LV, LT
Clone 3E7
Clone Type monoclonal
Conjugation Unconjugated
Description C3b/iC3b, Human, mAb 3E7 – 100 µg
Supplier Hycult biotechnology
Format 1 ml (100 µg/ml) 0.2 µm filtered antibody solution in PBS, containing 0.1% bovine serum albumin.
Immunogen C3b(i)-Sepharose
Isotype IgG1
Notes Understanding the Complement System: The Role of C3b/iC3b in Immune Response The complement system is integral to both innate and adaptive immune responses, capable of producing an inflammatory and protective reaction against pathogens. This system operates via three pathways of complement activation: the classical pathway, initiated by immune complexes; the lectin pathway, triggered by surface-bound mannan-binding lectin; and the alternative pathway (AP), which activates on unprotected surfaces. Each of these pathways generates a C3 convertase, a serine protease that cleaves C3, resulting in the formation of the crucial fragment C3b, a component central to understanding the C3b/iC3b dynamic. The Dynamics of C3b and iC3b in Complement Activation Upon activation, C3 splits into two fragments: the smaller anaphylatoxin C3a and the larger, short-lived C3b. C3b is highly reactive, binding to complement-activating particles or immune complexes. In contrast to the classical pathway, the AP is continuously active, playing a significant role in tissue damage and inflammation in autoimmune diseases and ischemia-reperfusion injury. Recent evidence suggests that inhibiting AP activation could reduce certain disease pathologies while maintaining the host defense mechanisms provided by the classical and lectin pathways. The Clinical Implications of C3b and iC3b C3b is a substance that can attach to the surfaces of cells. When this happens, it can mark the cells for destruction - a process known as opsonization. However, once C3b is attached to a cell, it can change into different, inactive forms. The most important of these is iC3b, followed by C3dg. This change from C3b to iC3b is very important because it helps control how active the complement system is. The complement system is a part of our immune system that helps fight diseases. By understanding how C3b changes into iC3b, scientists can find new ways to treat diseases where this part of the immune system is involved. Not sure which C3 antibody to use? With numerous options available, it is essential to select the right C3 antibody to ensure the success of your research. We designed a guide to assist you in making an informed decision: Go to our C3 researcher’s guide and choose the right antibody
Previous Article No 182-HM2286, 182-HM2286-100UG, HM2286-100UG
Product Type Antibodies Primary
Research area Immunology
Shipping Information Room Temperature
Size 100 µg
Source / Host mouse
Species Reactivity human
Storage Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
Substrate / Buffer Quantities >500 µg will be send without preservative and carrier free. Quantities
Product Page Updated 2024-04-05T09:42:44.568Z

References

Show more
Shipping info
The delivery time for this item is approximately 5-8 business days. Read more